Six months produces meaningful weight loss, typically 8 to 12%, but falls short of what longer treatment could achieve
Wegovy is best injected into the stomach, upper legs, or upper arms
GLP-1 drugs surge in popularity for treating obesity The backstory: GLP-1 drugs have surged in popularity in recent years for their effectiveness in treating obesity and diabetes
How they work: Your body releases growth hormone through a two-step process: one signal says "make GH" (that is CJC-1295's job) and another says "release it now" (that is Ipamorelin's job)
Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations
Novo Nordisk launched an oral form of Wegovy last month